However, its activity in the brain and central nervous system could theoretically influence areas regulating motivation and reward, which are linked to desire
The ability to achieve profound fat loss while maintaining functional lean tissue represents a significant advantage over traditional weight loss approaches
Verify #1 - Corporate entity
This level of weight loss significantly surpasses the efficacy seen with many currently available weight loss medications, including popular GLP-1 receptor agonists like semaglutide (found in Ozempic and Wegovy) and tirzepatide (found in Mounjaro and Zepbound)
When intake falls too far, the body reacts defensively by cutting energy spending on functions it treats as non-essential
The booming GLP-1 market, projected to reach $167bn by 2031, presents compelling opportunities for private equity players to carve out their niche and capture substantial value, despite industry giants Novo Nordisk and Eli Lilly dominating the lions share of the market.
